Tango Therapeutics

Latest clinical program signals indexed for Tango Therapeutics.

1. TNG908-C101 — Phase 2

   Jun 8, 2026
   Clinical update →

2. S095035 — Phase 2

   May 23, 2026
   Clinical update →

3. TNG260 — Phase 2

   May 23, 2026
   Clinical update →

4. TNG348 — Phase 2

   May 23, 2026
   Clinical update →

5. TNG456 — Phase 2

   May 23, 2026
   Clinical update →

6. TNG462 — Phase 2

   May 23, 2026
   Clinical update →

7. TNG908 — Phase 2

   May 23, 2026
   Clinical update →

1. 2024-511976-34-00

   TNG908-C101

   Phase 2 · active · small_molecule

   "Ph1: •Locally advanced (LA) or metastatic MTAP-deleted (met.MTAP-del.) solid tumors •MTAP-del.relapsed or refrac. Grade 4 astrocytoma or glioblastoma multiforme (R/R GBM) Ph2: A1:LA or met.MTAP-del. squamous and nonsquamous NSCLC A2:LA or met.MTAP-del. mesothelioma A3:LA or met.MTAP-del. sarcoma A4:LA or met.MTAP-del. pancreatic ductal adenocarcinoma or adenosquamous carcinoma w/predominantly adenocarcinoma histology A5:Other LA or met.MTAP-del. solid tumors A6:MTAP-del. R/R GBM"

   CTIS ↗
2. NCT05275478

   TNG908

   Phase 2 · terminated · small_molecule

   Locally Advanced Solid Tumor

   CT.gov ↗
3. NCT05732831

   TNG462

   Phase 2 · active · small_molecule

   Locally Advanced Solid Tumor

   CT.gov ↗
4. NCT05887492

   TNG260

   Phase 2 · active · small_molecule

   Non Small Cell Lung Cancer

   CT.gov ↗
5. NCT06065059

   TNG348

   Phase 2 · terminated · small_molecule

   Breast Cancer

   CT.gov ↗
6. NCT06188702

   S095035

   Phase 2 · active · small_molecule

   MTAP-deleted Solid Tumors

   CT.gov ↗
7. NCT06810544

   TNG456

   Phase 2 · active · small_molecule

   Non Small Cell Lung Cancer

   CT.gov ↗